Advances in Bladder Cancer Meeting

Friday 13 December 2019
Manchester Cancer Research Centre, Oglesby Cancer Research Building, 555 Wilmslow Road, Manchester, M20 4GJ

Registration is free for this event, hosted by the Manchester Cancer Research Centre at The University of Manchester.

9.15 Registration and coffee

9.45 Welcome and introduction - Professor Rob Bristow, The University of Manchester, Manchester Cancer Research Centre & The Christie NHS Foundation Trust

10.00 Biomarkers for MIBC - Professor Jason Efstathiou, Harvard Medical School

10.30 Hypoxia in bladder cancer - Professor Catharine West, University of Manchester

11.00 Immunotherapy and radiotherapy - Dr Rick Walshaw, University of Manchester

11.30 Tea/Coffee

12.00 Role of PARP inhibitors in bladder cancer - Professor Rob Bristow, The University of Manchester, Manchester Cancer Research Centre & The Christie NHS Foundation Trust

12.30 Pre-clinical evidence of novel agents and radiotherapy - Professor Anne Kiltie, University of Oxford

13.00 Lunch

13.45 Functional imaging in bladder cancer - Dr Valeria Panebianco, University of Rome

14.15 Dose and fractionation - Professor Peter Hoskin, University of Manchester & The Christie NHS Foundation Trust

14.45 Advances in radiotherapy - Professor Robert Huddart, The Royal Marsden NHS Foundation Trust

15.15 Tea/Coffee

15.45 Novel trial methodology in a biomarker era - Professor Emma Hall, The Institute of Cancer Research

16.15 Future clinical trials in bladder cancer - Professor Nick James, University of Birmingham & the Queen Elizabeth Hospital Birmingham

16.45 Closing remarks - Professor Ananya Choudhury, University of Manchester & The Christie NHS Foundation Trust

Contact details

For any queries relating to this event please contact:

Kimberley Reeves
The University of Manchester, c/o The NHS Foundation Trust
Wilmslow Road
Manchester
Greater Manchester
M20 4BX
United Kingdom
0161 446 8279